A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 2,922 shares of ANIK stock, worth $47,453. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,922
Previous 9,245 68.39%
Holding current value
$47,453
Previous $234 Million 69.18%
% of portfolio
0.01%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$24.25 - $28.75 $153,332 - $181,786
-6,323 Reduced 68.39%
2,922 $72.2 Million
Q2 2024

Aug 14, 2024

SELL
$24.57 - $28.47 $196,560 - $227,760
-8,000 Reduced 46.39%
9,245 $234 Million
Q1 2024

May 15, 2024

BUY
$21.95 - $26.42 $366,169 - $440,738
16,682 Added 2963.06%
17,245 $438 Million
Q4 2023

Feb 14, 2024

BUY
$18.47 - $23.3 $10,398 - $13,117
563 New
563 $12.8 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $237M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.